Get started
Author

Marie‐ange Lespinasse

Observed names: Lespinasse, Marie-Ange, Lespinasse, Marie‐ange, M.-A. Lespinasse, Marie-Ange Lespinasse, Marie-ange Lespinasse, Marie‐Ange Lespinasse
ORCID: 0000-0002-0784-6450
Observed ORCID: 0000-0002-0784-6450
OpenAlex ID: A5030253455
Uncovering new structural insights for antimalarial activity from cost-effective aculeatin-like derivatives
2014 · Matthias Winkler, Marjorie Maynadier, et al. · Organic & Biomolecular Chemistry · 30
Identification of specific reversal agents for Leishmania ABCI4-mediated antimony resistance by flavonoid and trolox derivative screening
2013 · J. I. Manzano, F. Lecerf-Schmidt, et al. · Journal of Antimicrobial Chemotherapy · 17
Crossing of the Cystic Barriers of Toxoplasma gondii by the Fluorescent Coumarin Tetra-Cyclopeptide
2021 · Céline Dard, Baptiste Leforestier, et al. · Molecules · 7
PDF
Enantioselective Approach for Expanding the Three‐Dimensional Space of Tetrahydroquinoline to Develop BET Bromodomain Inhibitors**
2022 · Marie‐Ange Lespinasse, Kaiyao Wei, et al. · Chemistry - A European Journal · 2
PDF
Photocyclization to form new cell permeable pseudocyclopeptides
2024 · Pérès, Basile, dos Santos, Leandro, J., et al. · HAL
CCDC 2143668: Experimental Crystal Structure Determination
2023 · Lespinasse, Marie-Ange, Wei, Kaiyao, et al. · The Cambridge Structural Database
Greener Pharmaceuticals: Short and Modular Enantioselective Organocatalyzed Synthesis of new BET Bromodomain Inhibitors with Anti-inflammatory Action
2022 · Wong, Yung-Sing, Lespinasse, Marie‐ange, et al. · HAL
Photocyclization to form new cell permeable cyclodepsipeptides
2022 · Pérès, Basile, dos Santos, Leandro, J., et al. · HAL
Greener Pharmaceuticals: Short Organocatalyzed Synthesis of BD2 Selective Bromodomain Inhibitors
2022 · Wong, Yung-Sing, Lespinasse, Marie‐ange, et al. · HAL
Works count: 11
Citation count: 56
H-index: 3
I10-index: 2
Year
Topic
Type